Short-term Outcomes After Spleen-preserving Minimally Invasive Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Pan-European Retrospective Study in High-volume Centers.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 Jan 2023
Historique:
pubmed: 7 6 2021
medline: 3 3 2023
entrez: 6 6 2021
Statut: ppublish

Résumé

To compare short-term clinical outcomes after Kimura and Warshaw MIDP. Spleen preservation during distal pancreatectomy can be achieved by either preservation (Kimura) or resection (Warshaw) of the splenic vessels. Multicenter studies reporting outcomes of Kimura and Warshaw spleen-preserving MIDP are scarce. Multicenter retrospective study including consecutive MIDP procedures intended to be spleen-preserving from 29 high-volume centers (≥15 distal pancreatectomies annually) in 8 European countries. Primary outcomes were secondary splenectomy for ischemia and major (Clavien-Dindo grade ≥III) complications. Sensitivity analysis assessed the impact of excluding ("rescue") Warshaw procedures which were performed in centers that typically (>75%) performed Kimura MIDP. Overall, 1095 patients after MIDP were included with successful splenic preservation in 878 patients (80%), including 634 Kimura and 244 Warshaw procedures. Rates of clinically relevant splenic ischemia (0.6% vs 1.6%, P = 0.127) and major complications (11.5% vs 14.4%, P = 0.308) did not differ significantly between Kimura and Warshaw MIDP, respectively. Mortality rates were higher after Warshaw MIDP (0.0% vs 1.2%, P = 0.023), and decreased in the sensitivity analysis (0.0% vs 0.6%, P = 0.052). Kimura MIDP was associated with longer operative time (202 vs 184 minutes, P = 0.033) and less blood loss (100 vs 150 mL, P < 0.001) as compared to Warshaw MIDP. Unplanned splenectomy was associated with a higher conversion rate (20.7% vs 5.0%, P < 0.001). Kimura and Warshaw spleen-preserving MIDP provide equivalent short-term outcomes with low rates of secondary splenectomy and postoperative morbidity. Further analyses of long-term outcomes are needed.

Sections du résumé

OBJECTIVE OBJECTIVE
To compare short-term clinical outcomes after Kimura and Warshaw MIDP.
BACKGROUND BACKGROUND
Spleen preservation during distal pancreatectomy can be achieved by either preservation (Kimura) or resection (Warshaw) of the splenic vessels. Multicenter studies reporting outcomes of Kimura and Warshaw spleen-preserving MIDP are scarce.
METHODS METHODS
Multicenter retrospective study including consecutive MIDP procedures intended to be spleen-preserving from 29 high-volume centers (≥15 distal pancreatectomies annually) in 8 European countries. Primary outcomes were secondary splenectomy for ischemia and major (Clavien-Dindo grade ≥III) complications. Sensitivity analysis assessed the impact of excluding ("rescue") Warshaw procedures which were performed in centers that typically (>75%) performed Kimura MIDP.
RESULTS RESULTS
Overall, 1095 patients after MIDP were included with successful splenic preservation in 878 patients (80%), including 634 Kimura and 244 Warshaw procedures. Rates of clinically relevant splenic ischemia (0.6% vs 1.6%, P = 0.127) and major complications (11.5% vs 14.4%, P = 0.308) did not differ significantly between Kimura and Warshaw MIDP, respectively. Mortality rates were higher after Warshaw MIDP (0.0% vs 1.2%, P = 0.023), and decreased in the sensitivity analysis (0.0% vs 0.6%, P = 0.052). Kimura MIDP was associated with longer operative time (202 vs 184 minutes, P = 0.033) and less blood loss (100 vs 150 mL, P < 0.001) as compared to Warshaw MIDP. Unplanned splenectomy was associated with a higher conversion rate (20.7% vs 5.0%, P < 0.001).
CONCLUSIONS CONCLUSIONS
Kimura and Warshaw spleen-preserving MIDP provide equivalent short-term outcomes with low rates of secondary splenectomy and postoperative morbidity. Further analyses of long-term outcomes are needed.

Identifiants

pubmed: 34091515
doi: 10.1097/SLA.0000000000004963
pii: 00000658-900000000-93532
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e119-e125

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Asbun HJ, Moekotte AL, Vissers FL, et al. The Miami International evidence-based guidelines on minimally invasive pancreas resection. Ann Surg. 2020;271:1–14.
Bjornsson B, Larsson AL, Hjalmarsson C, et al. Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial. Br J Surg. 2020;107:1281–1288.
de Rooij T, van Hilst J, van Santvoort H, et al. Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg. 2019;269:2–9.
Casciani F, Trudeau MT, Vollmer CM Jr. Perioperative immunization for splenectomy and the surgeon’s responsibility: a review. JAMA Surg. 2020;155:1068–1077.
Finnegan OC, Hawkey PM. Overwhelming post-splenectomy infection with group B Streptococcus. Postgrad Med J. 1981;57:202–203.
Likhite VV. Immunological impairment and susceptibility to infection after splenectomy. JAMA. 1976;236:1376–1377.
Taniguchi LU, Correia MD, Zampieri FG. Overwhelming post-splenectomy infection: narrative review of the literature. Surg Infect (Larchmt). 2014;15:686–693.
Kristinsson SY, Gridley G, Hoover RN, et al. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica. 2014;99:392–398.
Kimura W, Fuse A, Hirai I, et al. Spleen-preserving distal pancreatectomy with preservation of the splenic artery and vein for intraductal papillary-mucinous tumor (IPMT): three interesting cases. Hepatogastroenterology. 2003;50:2242–2245.
Maggino L. 958 - Splenectomy During Distal Pancreatectomy: What are we Really Doing? SSAT Abstracts 2018 2018.
Warshaw AL. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123:550–553.
Sutherland DE, Najarian JS. Conservation of the spleen with distal pancreatectomy. Arch Surg. 1988;123:1525.
Elabbasy F, Gadde R, Hanna MM, et al. Minimally invasive spleen-preserving distal pancreatectomy: does splenic vessel preservation have better postoperative outcomes? A systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int. 2015;14:346–353.
Hou B, Xiong D, Chen S, et al. Splenic vessel preservation versus splenic vessel resection in laparoscopic spleen-preserving distal pancreatectomy. ANZ J Surg. 2018;88:E532–E538.
Jain G, Chakravartty S, Patel AG. Spleen-preserving distal pancreatectomy with and without splenic vessel ligation: a systematic review. HPB (Oxford). 2013;15:403–410.
Li BQ, Qiao YX, Li J, et al. Preservation or ligation of splenic vessels during spleen-preserving distal pancreatectomy: a meta-analysis. J Invest Surg. 2019;32:654–669.
Partelli S, Cirocchi R, Randolph J, et al. A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein. Surgeon. 2016;14:109–118.
Song J, He Z, Ma S, et al. Clinical comparison of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A. 2019;29:323–332.
Sun N, Lu G, Zhang L, et al. Clinical efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis. Medicine (Baltimore). 2017;96:e8600.
Tang Y, Tang S, Hu S. The efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis. Int J Clin Exp Med. 2015;8:17128–17139.
Yongfei H, Javed AA, Burkhart R, et al. Geographical variation and trends in outcomes of laparoscopic spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis. Int J Surg. 2017;45:47–55.
Yu X, Li H, Jin C, et al. Splenic vessel preservation versus Warshaw’s technique during spleen-preserving distal pancreatectomy: a meta-analysis and systematic review. Langenbecks Arch Surg. 2015;400:183–191.
Paiella S, De Pastena M, Korrel M, et al. Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: international multicenter retrospective study. Eur J Surg Oncol. 2019;45:1668–1673.
Esposito A, Casetti L, De Pastena M, et al. Robotic spleen-preserving distal pancreatectomy: the Verona experience. Updates Surg. 2021;73:923–928.
Lof S, Korrel M, van Hilst J, et al. Outcomes of elective and emergency conversion in minimally invasive distal pancreatectomy for pancreatic ductal adenocarcinoma: an international multicenter propensity score-matched study. Ann Surg. 2021;274:e1001–e1007.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.
Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–768.
Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20–25.
Dai MH, Shi N, Xing C, et al. Splenic preservation in laparoscopic distal pancreatectomy. Br J Surg. 2017;104:452–462.
Mekeel KL, Moss AA, Reddy KS, et al. Laparoscopic distal pancreatectomy: does splenic preservation affect outcomes? Surg Laparosc Endosc Percutan Tech. 2011;21:362–365.
Tang CW, Feng WM, Bao Y, et al. Spleen-preserving distal pancreatectomy or distal pancreatectomy with splenectomy?: perioperative and patient-reported outcome analysis. J Clin Gastroenterol. 2014;48:e62–e66.
Dokmak S. Medial or lateral approach for laparoscopic splenic vessel-preserving distal pancreatectomy? Surgery. 2012;152:143–144.
Ferrone CR, Konstantinidis IT, Sahani DV, et al. Twenty-three years of the Warshaw operation for distal pancreatectomy with preservation of the spleen. Ann Surg. 2011;253:1136–1139.
Shi N, Liu SL, Li YT, et al. Splenic preservation versus splenectomy during distal pancreatectomy: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23:365–374.
Tsiouris A, Cogan CM, Velanovich V. Distal pancreatectomy with or without splenectomy: comparison of postoperative outcomes and surrogates of splenic function. HPB (Oxford). 2011;13:738–744.
Moekotte AL, Lof S, White SA, et al. Splenic preservation versus splenectomy in laparoscopic distal pancreatectomy: a propensity score-matched study. Surg Endosc. 2020;34:1301–1309.
Zhao YP, Du X, Dai MH, et al. Laparoscopic distal pancreatectomy with or without splenectomy: spleen-preservation does not increase morbidity. Hepatobiliary Pancreat Dis Int. 2012;11:536–541.

Auteurs

Maarten Korrel (M)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of General Surgery, Fondazione Poliambulanza Hospital, Brescia, Italy.

Sanne Lof (S)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.
Department of General Surgery, Fondazione Poliambulanza Hospital, Brescia, Italy.

Bilal Al Sarireh (B)

Department of Surgery, Morriston Hospital, Swansea, United Kingdom.

Bergthor Björnsson (B)

Department of Surgery and Department of Biomedical and Clinical Sciences, Linköping University, Sweden.

Ugo Boggi (U)

Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.

Giovanni Butturini (G)

Department of Surgery, Pederzoli Hospital, Peschiera, Italy.

Riccardo Casadei (R)

Department of Surgery, S. Orsola-Malpighi Hospital, Bologna, Italy.

Matteo De Pastena (M)

Department of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.

Alessandro Esposito (A)

Department of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.

Jean Michel Fabre (JM)

Department of Surgery, University Hospital Saint-Eloi, Montpellier, France.

Giovanni Ferrari (G)

Department of Surgery, Niguarda Ca' Granda Hospital, Milan, Italy.

Fadhel Samir Fteriche (FS)

Department of Surgery, Hospital of Beaujon, Clichy, France.

Giuseppe Fusai (G)

Department of Surgery, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.

Bas Groot Koerkamp (BG)

Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Thilo Hackert (T)

Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Asif Jah (A)

Department of Hepatobiliary and Pancreatic Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom.

Tobias Keck (T)

Department of Surgery, University Hospital Schleswig Holstein, Campus Lübeck, Lübeck, Germany.

Marco V Marino (MV)

Emergency and General Surgery Department, Hospital Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy and General Surgery Department, Abano Terme General Hospital, Italy.

I Quintus Molenaar (IQ)

Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, the Netherlands.

Patrick Pessaux (P)

Department of Visceral and Digestive Surgery, University Hospital of Strasbourg, Strasbourg, France.

Andrea Pietrabissa (A)

Department of Surgery, University Hospital Pavia, Pavia, Italy.

Edoardo Rosso (E)

Department of General Surgery, Fondazione Poliambulanza Hospital, Brescia, Italy.
Department of Visceral and Digestive Surgery, University Hospital of Strasbourg, Strasbourg, France.

Mushegh Sahakyan (M)

The Intervention Center, Department of HPB Surgery, Department of Research & Development, Division of Emergencies and Critical Care Oslo University Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Research & Development, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.

Zahir Soonawalla (Z)

Department of Surgery, Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom.

Francois Regis Souche (FR)

Department of Surgery, University Hospital Saint-Eloi, Montpellier, France.

Steve White (S)

Department of Surgery, University Hospital Saint-Eloi, Montpellier, France.

Alessandro Zerbi (A)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; and.
Humanitas Research Hospital, Rozzano, Italy.

Safi Dokmak (S)

Department of Surgery, Hospital of Beaujon, Clichy, France.

Bjorn Edwin (B)

The Intervention Center, Department of HPB Surgery, Department of Research & Development, Division of Emergencies and Critical Care Oslo University Hospital and Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Mohammad Abu Hilal (MA)

Department of General Surgery, Fondazione Poliambulanza Hospital, Brescia, Italy.
Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom.

Marc Besselink (M)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH